Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product

The engagement aims for JS First to conduct comprehensive research on manufacturing and licensing rights for Clearmind's MEAI-based beverages in foreign markets, identify and secure high-quality manufacturing partners in multiple countries and establish relationships with distributors across the globe, including in the U.S., Europe, Africa and Southeast Asia, for widespread market penetration. Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development o ...